| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.39 | 0.03 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |